November 12, 2026
“AstraZeneca (AZN), Britain’s biggest pharmaceutical company, said on Friday that its profit after tax rose 23% to $3.12 billion (€2.79bn) for the July to September period, driven largely by its cancer treatments. That marks a sharp pick-up from the rise… Continue Reading…

Recent Comments